Citizens Financial Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.39M Buy
28,058
+1,096
+4% +$97.7K 0.03% 258
2025
Q4
$2.13M Buy
26,962
+2,598
+11% +$204K 0.03% 279
2025
Q3
$1.95M Buy
24,364
+3,690
+18% +$315K 0.03% 288
2025
Q2
$1.88M Buy
20,674
+4,663
+29% +$426K 0.03% 264
2025
Q1
$1.5M Sell
16,011
-553
-3% -$49.5K 0.03% 267
2024
Q4
$1.51M Sell
16,564
-841
-5% -$80.3K 0.03% 249
2024
Q3
$1.81M Buy
17,405
+91
+0.5% +$9.28K 0.04% 226
2024
Q2
$1.68M Buy
17,314
+3,232
+23% +$298K 0.04% 224
2024
Q1
$1.27M Buy
14,082
+1,549
+12% +$131K 0.04% 190
2023
Q4
$999K Buy
12,533
+1,967
+19% +$148K 0.03% 222
2023
Q3
$751K Sell
10,566
-20,315
-66% -$1.52M 0.03% 206
2023
Q2
$2.38M Sell
30,881
-440
-1% -$34.1K 0.09% 151
2023
Q1
$2.35M Buy
31,321
+994
+3% +$73.9K 0.09% 156
2022
Q4
$2.39M Sell
30,327
-684
-2% -$51.3K 0.09% 135
2022
Q3
$2.18M Sell
31,011
-667
-2% -$52.3K 0.1% 138
2022
Q2
$2.54M Sell
31,678
-663
-2% -$51.8K 0.11% 129
2022
Q1
$2.45M Buy
32,341
+601
+2% +$47.6K 0.09% 137
2021
Q4
$2.71M Sell
31,740
-27
-0.1% -$2.11K 0.09% 141
2021
Q3
$2.4M Sell
31,767
-95
-0.3% -$7.54K 0.09% 143
2021
Q2
$2.59M Sell
31,862
-1,715
-5% -$140K 0.11% 121
2021
Q1
$2.65M Buy
33,577
+660
+2% +$51.7K 0.14% 110
2020
Q4
$2.81M Buy
32,917
+2,994
+10% +$248K 0.16% 104
2020
Q3
$2.31M Sell
29,923
-2,435
-8% -$186K 0.15% 106
2020
Q2
$2.37M Buy
32,358
+1,992
+7% +$142K 0.17% 103
2020
Q1
$2.02M Sell
30,366
-952
-3% -$67.1K 0.16% 104
2019
Q4
$2.16M Sell
31,318
-346
-1% -$23.6K 0.14% 111
2019
Q3
$2.33M Sell
31,664
-522
-2% -$37.9K 0.17% 100
2019
Q2
$2.31M Sell
32,186
-113
-0.3% -$8.02K 0.17% 99
2019
Q1
$2.21M Sell
32,299
-487
-1% -$31.5K 0.16% 102
2018
Q4
$1.95M Sell
32,786
-1,299
-4% -$81.3K 0.18% 97
2018
Q3
$2.28M Sell
34,085
-760
-2% -$50.6K 0.18% 97
2018
Q2
$2.26M Sell
34,845
-1,509
-4% -$98.7K 0.19% 95
2018
Q1
$2.61M Sell
36,354
-310
-0.8% -$22.3K 0.22% 92
2017
Q4
$2.77M Sell
36,664
-1,295
-3% -$94.6K 0.22% 87
2017
Q3
$2.77M Buy
37,959
+2,983
+9% +$215K 0.24% 90
2017
Q2
$2.59M Sell
34,976
-2,195
-6% -$163K 0.23% 94
2017
Q1
$2.72M Sell
37,171
-86,509
-70% -$6.06M 0.24% 91
2016
Q4
$8.09M Sell
123,680
-7,756
-6% -$532K 0.78% 46
2016
Q3
$9.74M Sell
131,436
-881
-0.7% -$65.1K 0.92% 40
2016
Q2
$9.69M Sell
132,317
-695
-0.5% -$49.5K 0.93% 39
2016
Q1
$9.4M Buy
133,012
+2,125
+2% +$141K 0.9% 41
2015
Q4
$9.07M Buy
+130,887
New +$8.71M 0.86% 44

Other funds holding CL

Citizens Financial Group's CL Position: Q1 2026 in Review

Citizens Financial Group increased its Colgate-Palmolive (CL) stake by 4.1% in Q1 2026, buying an estimated $97.7K and bringing the position to 28,058 shares worth $2.39M. The position accounts for 0.03% of the portfolio, ranked #258.

Citizens Financial Group first reported a position in CL in Q4 2015 and has held it in 42 quarters since. The position peaked at $9.74M in Q3 2016. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Citizens Financial Group held 28,058 shares of Colgate-Palmolive worth $2.39M as of Q1 2026.
  • Citizens Financial Group bought 1,096 Colgate-Palmolive shares in Q1 2026, an estimated $97.7K.
  • Colgate-Palmolive made up 0.03% of Citizens Financial Group's portfolio in Q1 2026, its #258 holding.
  • Citizens Financial Group first reported a position in Colgate-Palmolive in Q4 2015 and has held it in 42 quarters since.
  • Citizens Financial Group's Colgate-Palmolive position peaked at $9.74M in Q3 2016.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Citizens Financial Group's 13F filing for Q1 2026, filed 1 May 2026.